.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

McKesson
AstraZeneca
Colorcon
Daiichi Sankyo
Harvard Business School
Covington
Johnson and Johnson
Cerilliant
US Department of Justice
Cantor Fitzgerald

Generated: September 25, 2017

DrugPatentWatch Database Preview

THEOCLEAR L.A.-260 Drug Profile

« Back to Dashboard

Which patents cover Theoclear L.a.-260, and when can generic versions of Theoclear L.a.-260 launch?

Theoclear L.a.-260 is a drug marketed by Schwarz Pharma and is included in one NDA.

The generic ingredient in THEOCLEAR L.A.-260 is theophylline. There are thirty-six drug master file entries for this compound. Thirty suppliers are listed for this compound. Additional details are available on the theophylline profile page.

Summary for Tradename: THEOCLEAR L.A.-260

Patents:0
Applicants:1
NDAs:1
Bulk Api Vendors: see list28
Clinical Trials: see list117
Patent Applications: see list9,694
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:THEOCLEAR L.A.-260 at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Schwarz Pharma
THEOCLEAR L.A.-260
theophylline
CAPSULE, EXTENDED RELEASE;ORAL086569-002May 27, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

AstraZeneca
Queensland Health
Federal Trade Commission
Colorcon
Harvard Business School
Moodys
Healthtrust
Dow
Daiichi Sankyo
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot